The 22nd PBMI Annual Drug Benefit Conference is set for March 6-8 in Orlando, Florida. Read More »

New data from the Centers for Medicare and Medicaid Services shows that major chain pharmacies such as CVS, Walgreens and Walmart account for over 79 percent of Prescription Drug Plans for the elderly. Read More »

Following recent public reaction to the price of epinephrine auto-injector pens, known as “epi-pens,” and the desire for an affordable alternative, CVS Health intends to market authorized generic version two-packs for $109.99 apiece. Read More »

A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »

Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs. Read More »

Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »

The public relations departments at American pharmaceutical manufacturers can’t be too pleased about the results of a new Harris Poll out this week that shows only nine percent of U.S. consumers believe “pharmaceutical and biotechnology companies put patients over profits.” Read More »

Two pharmaceutical giants — Sanofi and Regeneron — face a forced marketing shutdown of a high-priced cholesterol medication following a decision recently handed down by a U.S. District Court in Delaware ruling patent infringement of another medication. Read More »

Mylan N.V, a major distributor of over the counter medications, has acquired popular cold medication Cold-Eeze from ProPhase Labs Inc. Read More »

The U.S. Food and Drug Administration has approved Sangamo BioSciences Inc.'s Investigational New Drug Application for the SB-525 gene therapy program for patients with hemophilia A. Read More »

Custopharm Inc., a U.S. producer of generic injectable devices, has acquired two Paragraph IV abbreviated new drug application products from Perrigo Co. PLC. Read More »

Amorsa Therapeutics, a neuropharmaceutical company specializing in treating nervous system disorders, has entered a partnership with Janssen Pharmaceuticals Inc. Read More »

Ionis Pharmaceuticals Inc. and Akcea Therapeutics, an Ionis subsidiary, recently announced a partnership with Novartis to develop and commercialize the drugs AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx. Read More »

Expanding their existing relationship, Community Health Network will manage 12 retail health clinics in Walgreens stores across central Indiana. Read More »

EnteroMedics Inc. has retired its Senior Amortizing Convertible Notes, converted all $18.75 million in notes to shares of common stock, as part of a strategy to regain compliance with the Nasdaq requirement that it have a minimum of $2.5 million of stockholders’ equity. Read More »

Sanofi's Soliqua 100/33 product to treat adults with Type 2 diabetes is now available via prescription in U.S. pharmacies. Read More »

MiMedx Group Inc. has filed lawsuits against two former sales employees for alleged breaches of contractual and common law obligations. Read More »

Factor One Source Pharmacy, a specialty pharmacy that serves individuals with complex or hard-to-manage medications, will acquire Fast Access Specialty Therapeutics, a quickly growing pharmacy that has made a name for itself through industry-leading customer satisfaction, patient engagement and strong financial performance. Read More »

Bayer AG and Versant Ventures recently announced a partnership to launch BlueRock Therapeutics. The joint venture will utilize breakthrough treatments in stem cell technology to cure a range of diseases. Read More »

CVS Health recently launched Transform Diabetes Care, a program dedicated to helping clients improve member health outcomes. Read More »